A Placebo-Controlled Trial of Memantine for Alcohol Dependence
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain a preliminary indication of the safety and
effectiveness of oral memantine (40 mg/day) in alcohol dependent patients. This study is a
16-week study comparison of memantine and placebo in patients with alcohol dependence.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)